The abstract is read at the publisher; the summary is JClub's.
Extrachromosomal circular DNA (eccDNA) in human cancer shows a broad size distribution and chromosome independence, and its genomic distribution is linked to clinical biomarker potential.
- Why it matters: The field lacks a complete understanding of how eccDNA is generated and how it functions in tumorigenesis, limiting its translation into reliable diagnostics and therapies.
- What they did: This review synthesizes emerging biogenesis mechanisms, highlighting the recently described single-strand break driven internal loop (i-loop) model, and surveys detection methods and proposed roles in cancer.
- The result: eccDNA is discussed as contributing to oncogene amplification, tumor heterogeneity, cell death, tumor immunity, and drug resistance, supporting its evaluation as diagnostic, prognostic, predictive biomarker and therapeutic vulnerability.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.